Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s | ...

A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The ...

Serena Williams says she has lost weight using GLP-1 medication. The drugs help manage blood sugar and promote weight loss, ...

A new Business Group on Health survey finds that nearly a quarter of all employer healthcare spending (24%) went to pharmacy ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025 ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

Among those exposed to GLP-1s, 7.2% developed AKI within the first 90 days of initiation of anticancer therapies, compared with 6.4% of those with no GLP-1 exposure (n = 13,505).